Genmab Acquires ADC Drug Developer ProfoundBio for US$1.8 B

By Lucy Haggerty

Pharma Deals Review: Vol 2024 Issue 4 (Table of Contents)

Published: 5 Apr-2024

DOI: 10.3833/pdr.v2024.i4.2868     ISSN: 1756-7874

Section: Mergers & Acquisitions



In a bid to bolster its oncology portfolio, Genmab has agreed to acquire ProfoundBio in an all-cash transaction for a total of US$1...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details